To further investigate whether CREB3L2 expression is associated with the clinicopathologic features or long-term survival of patients with HCC, immunohistochemistry was performed on tissue microarrays to detect CREB3L2 expression in 176 patients with HCC (Cohort 2). The gene discussed is CREB3L2; the disease is hepatocellular carcinoma.